Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients

Journal of Cardiology

Volumn 65, Issue 5, 2015, Pages 403-411

  Berezin, Alexander E ^a   Kremzer, Alexander A ^a   Samura, Tatyana A ^a   Martovitskaya, Yulia V ^a   Malinovskiy, Yaroslav V ^b   Oleshko, Sergey V ^b   Berezina, Tatyana A ^c  

^a ZAPORIZHZHIA STATE MEDICAL UNIVERSITY   (Ukraine)

^b Regional Cardiology Center   (Ukraine)

^c Private Medical Center Vita Center   (Ukraine)

Author keywords

Advanced chronic heart failure; Endothelial derived apoptotic microparticles; Proangiogenic mononuclear cells; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVOSIMENDAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; ACUTELY DECOMPENSATED CHRONIC HEART FAILURE; ADULT; ARTICLE; BLOOD CELL RATIO; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ENDOTHELIAL DERIVED APOPTOTIC MICROPARTICLE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; MIDDLE AGED; MONONUCLEAR CELL; MONONUCLEAR PROGENITOR CELL RATIO; NEW YORK HEART ASSOCIATION CLASS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PROGNOSIS; SEX DIFFERENCE; STEM CELL; SYSTOLIC BLOOD PRESSURE; AGED; APOPTOSIS; BIOLOGICAL MODEL; BLOOD; CHRONIC DISEASE; CLASSIFICATION; HEART FAILURE; KAPLAN MEIER METHOD; PATHOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

AGED; APOPTOSIS; BIOMARKERS; CELL-DERIVED MICROPARTICLES; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STEM CELLS;

EID: 84928923989     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.06.014     Document Type: Article

References (42)

1. Filippatos G., Farmakis D., Bistola V., Karavidas A., Mebazaa A., Maggioni A.P., Parissis J.T. Temporal trends in epidemiology, clinical presentation and management of acute heart failure: results from the Greek cohorts of the Acute Heart Failure Global Registry of Standard Treatment and the European Society of Cardiology-Heart Failure pilot survey. Eur Heart J Acute Cardiovasc Care 2014, (March). [Epub ahead of print].
2. Lindenfeld J., Albert N.M., Boehmer J.P., Collins S.P., Ezekowitz J.A., Givertz M.M., Klapholz M., Moser D.K., Rogers J.G., Starling R.C., Stevenson W.G., Tang W.H.W., Teerlink J.R., Walsh M.N. Executive summary: HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010, 16:475e-539e.
3. Kalogeropoulos A.P., Tang W.H., Hsu A., Felker G.M., Hernandez A.F., Troughton R.W., Voors A.A., Anker S.D., Metra M., McMurray J.J., Massie B.M., Ezekowitz J.A., Califf R.M., O'Connor C.M., Starling R.C., et al. High sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. J Card Fail 2014, 20:319-326.
4. Alhabib K.F., Elasfar A.A., Alfaleh H., Kashour T., Hersi A., Albackr H., Alshaer F., Alnemer K., Hussein G.A., Mimish L., Almasood A., Alhabeeb W., Alghamdi S., Alsharari M., Chakra E., et al. Clinical features, management, and short- and long-term outcomes of patients with acute decompensated heart failure: phase I results of the HEARTS database. Eur J Heart Fail 2014, (February). [Epub ahead of print]. 10.1002/ejhf.57.
5. Fonarow G.C., Albert N.M., Curtis A.B., Stough W.G., Gheorghiade M., Heywood J.T., McBride M.L., Inge P.J., Mehra M.R., O'Connor C.M., Reynolds D., Walsh M.N., Yancy C.W. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation 2010, 122:585-596.
6. Patterson M.E., Hernandez A.F., Hammill B.G., Fonarow G.C., Peterson E.D., Schulman K.A., Curtis L.H. Process of care performance measures and long-term outcomes in patients hospitalized with heart failure. Med Care 2010, 48:210-211.
7. Logeart D., Thabut G., Jourdain P., Chavelas C., Beyne P., Beauvais F., Bouvier E., Solal A.C. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004, 43:635-641.
8. Metra M., Nodari S., Parrinello G., Specchia C., Brentana L., Rocca P., Fracassi F., Bordonali T., Milani P., Danesi R., Verzura G., Chiari E., Dei Cas L. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail 2007, 9:776-786.
9. Noveanu M., Breidthardt T., Potocki M., Reichlin T., Twerenbold R., Uthoff H., Socrates T., Arenja N., Reiter M., Meissner J., Heinisch C., Stalder S., Mueller C. Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure. Crit Care 2011, 15:R1.
10. Valle R., Aspromonte N., Milani L., Peacock F.W., Maisel A.S., Santini M., Ronco C. Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. Heart Fail Rev 2011, 16:519-529.
11. Xue Y., Clopton P., Peacock W.F., Maisel A.S. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail 2011, 13:37-42.
12. Disomma S., Magrini L., Pittoni V., Marino R., Peacock W.F., Maisel A. Usefulness of serial assessment of natriuretic peptides in the emergency department for patients with acute decompensated heart failure. Congest Heart Fail 2008, 14(4 Suppl. 1):21-24.
13. Lainchbury J.G., Troughton R.W., Strangman K.M., Frampton C.M., Pilbrow A., Yandle T.G., Hamid A.K., Nicholls M.G., Richards A.M. N-terminal Pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol 2009, 55:53-60.
14. Rajendran P., Rengarajan T., Thangavel J., Nishigaki Y., Sakthisekaran D., Sethi G., Nishigaki I. The vascular endothelium and human diseases. Int J Biol Sci 2013, 9:1057-1069.
15. Matsuzawa Y., Sugiyama S., Sumida H., Sugamura K., Nozaki T., Ohba K., Matsubara J., Kurokawa H., Fujisue K., Konishi M., Akiyama E., Suzuki H., Nagayoshi Y., Yamamuro M., Sakamoto K., et al. Peripheral endothelial function and cardiovascular events in high-risk patients. J Am Heart Assoc 2013, 2:e000426.
16. Markiewicz M., Richard E., Marks N., Ludwicka-Bradley A. Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases. J Aging Res 2013, 2013:734509.
17. Berezin A.E., Kremzer A.A. Circulating endothelial progenitor cells as markers for severity of ischemic chronic heart failure. J Card Fail 2014, 20:438-447.
18. Horstman L.L., Jy W., Jimenez J.J., Ahn Y.S. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004, 9:1118-1135.
19. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
20. Berezin A.E., Kremzer A.A., Samura T.A., Martovitskaya Y.V. Apoptotic microparticles to progenitor mononuclear cells ratio in heart failure: relevance of clinical status and outcomes. J Cardiovasc Dis 2014, 2. [Epub ahead of print]. http://www.researchpub.org/journal/jcvd/jcvd.html.
21. Catapano A.L., Reiner Z., De Backer G., Graham I., Taskinen M.R., Wiklund O., Agewall S., Alegria E., Chapman M., Durrington P., Erdine S., Halcox J., Hobbs R., Kjekshus J., Filardi P.P., et al. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011, 217:3-46.
22. Mancia G., Fagard R., Narkiewicz K., Redón J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., Galderisi M., Grobbee D.E., Jaarsma T., Kirchhof P., Kjeldsen S.E., et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013, 31:1281-1357.
23. Sacks D.B., Arnold M., Bakris G.L., Bruns D.E., Horvath A.R., Kirkman M.S., Lernmark A., Metzger B.E., Nathan D.M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011, 57:e1-e47.
24. Bluemke D.A., Achenbach S., Budoff M., Gerber T.C., Gersh B., Hillis L.D., Hundley W.G., Manning W.J., Printz B.F., Stuber M., Woodard P.K. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Circulation 2008, 118:586-606.
25. Schiller N.B., Shah P.M., Crawford M., De Maria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
26. Pellerin D., Sharma R., Elliott P., Veyrat C. Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 2003, 89:iii9-iii17.
27. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612. For the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration).
28. Orozco A.F., Lewis D.E. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010, 77:502-514.
29. Lacroix R., Judicone C., Mooberry M., Boucekine M., Key N.S., Dignat-George F. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2013, (April). The ISTH SSC Workshop, [Epub ahead of print]. 10.1111/jth.12207.
30. Tung J.W., Parks D.R., Moore W.A., Herzenberg L.A., Herzenberg L.A. New approaches to fluorescence compensation and visualization of FACS data. Clin Immunol 2004, 110:277-283.
31. Jimenez J.J., Jy W., Mauro L.M., Soderland C., Horstman L.L., Ahn Y.S. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003, 109:175-180.
32. Bueno Jiménez C. Circulating microparticles from patients with coronary artery disease cause endothelial dysfunction. Rev Esp Cardiol (Engl Ed) 2012, 65:389.
33. Boulanger C.M., Scoazec A., Ebrahimian T., Henry P., Mathieu E., Tedgui A., Mallat Z. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001, 104:2649.
34. Bulut D., Maier K., Bulut-Streich N., Borgel J., Hanefeld C., Mugge A. Circulating endothelial microparticles correlate inversely with endothelial function in patients with ischemic left ventricular dysfunction. J Card Fail 2008, 14:336-340.
35. Sinning J.M., Losch J., Walenta K., Böhm M., Nickenig G., Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2011, 32:2034-2041.
36. António N., Soares A., Carvalheiro T., Fernandes R., Paiva A., Ventura M., Cristóvão J., Elvas L., Gonçalves L., Providência L.A., Fontes Ribeiro C., Mariano Pego G. Circulating endothelial progenitor cells as a predictor of response to cardiac resynchronization therapy: the missing piece of the puzzle?. Pacing Clin Electrophysiol 2014, (January). [Epub ahead of print]. 10.1111/pace.12334.
37. Alba A.C., Lalonde S.D., Rao V., Walter S.D., Guyatt G.H., Ross H.J. Changes in circulating progenitor cells are associated with outcome in heart failure patients: a longitudinal study. Can J Cardiol 2013, 29:1657-1664.
38. Consoli C., Gatta L., Iellamo F., Molinari F., Rosano G.M., Marlier L.N. Severity of left ventricular dysfunction in heart failure patients affects the degree of serum-induced cardiomyocyte apoptosis. Importance of inflammatory response and metabolism. Int J Cardiol 2013, 167:2859-2866.
39. Berezin A.E., Kremzer A.A. Analysis of various subsets of circulating mononuclear cells in asymptomatic coronary artery disease. J Clin Med 2013, 2:32-44.
40. Shudo Y., Cohen J.E., Macarthur J.W., Atluri P., Hsiao P.F., Yang E.C., Fairman A.S., Trubelja A., Patel J., Miyagawa S., Sawa Y., Woo Y.J. Spatially oriented, temporally sequential smooth muscle cell-endothelial progenitor cell bi-level cell sheet neovascularizes ischemic myocardium. Circulation 2013, 128(11 Suppl. 1):S59-S68.
41. Konenkov V.I., Pokushalov E.A., Poveshchenko O.V., Kim I.I., Romanov A.B., Guleva N.A., Bernvald V.V., Soloviova A.O., Yankayte E.V., Poveshchenko A.F., Karaskov A.M. Phenotype of peripheral blood cells mobilized by granulocyte colony-stimulating factor in patients with chronic heart failure. Bull Exp Biol Med 2012, 153:124-128.
42. Alba A.C., Delgado D.H., Rao V., Walter S., Guyatt G., Ross H.J. Are endothelial progenitor cells a prognostic factor in patients with heart failure. Expert Rev Cardiovasc Ther 2012, 10:167-175.